Rain Oncology (RAIN) - 2023 Q2 - Quarterly Report
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40356 Rain Oncology Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 82-1130967 (State or other jurisdiction of incorporation or organization) 8000 Jarvis Avenue, Suite 204 Newark, CA 94560 ☒ QUARTERLY REPORT PURSUANT TO SECT ...